Menu
Back to Equity and Access
07/23/26

It depends on where you stand on screening: health professionals' awareness, perspectives, and approaches to overdiagnosis in cancer screening - a qualitative interview study.

Piessens, Veerle; Lauwerier, Emelien; Brodersen, John Brandt; Ceuterick, Melissa; Jønsson, Alexandra Brandt Ryborg; Van den Bruel, Ann; Heytens, Stefan. BMC Health Serv Res.

Collection Topics
Big Three Conditions Overdiagnosis Tests, Screening, and Laboratory Processes
Share

Most recent

Comparative cost of care recommended by large language models versus treating physicians.

Aran, Goldhaber-Fiebert, Many, et al., NEJM AI
10/15/26 Business Case for Excellence Tests, Screening, and Laboratory Processes

Effect of screening with multicancer early-detection test on late-stage cancer diagnosis.

Sasieni, Johnson, Round, et al., New Engl J Med.
09/22/26 Big Three Conditions Equity, Access, and Timeliness Tests, Screening, and Laboratory Processes

Beyond root cause analysis: a practical systems engineering approach to incident investigation in histopathology.

Rakha, Rakha, J Clin Pathol.
09/18/26 Measurement, Monitoring, and Event Analysis Tests, Screening, and Laboratory Processes

Summary

Overdiagnosis remains an under-recognized diagnostic harm. This qualitative Belgian study examined the perspectives of 34 health professionals involved in breast, lung, or prostate screening. Few participants naturally identified overdiagnosis as a screening harm, and their responses varied according to their broader views of screening. The findings illustrate how professional beliefs and context can shape diagnostic decisions.
Read the paper
Piessens V, Lauwerier E, Brodersen JB, et al. It depends on where you stand on screening: health professionals’ awareness, perspectives, and approaches to overdiagnosis in cancer screening - a qualitative interview study. BMC Health Serv Res. 2026;26(1):1179.